While it’s common to say a company has experience with a certain technology, it is the people at that firm who are able to utilize equipment and procedures in successful applications of technology.
While many companies have experience with early-phase work, it’s important to dig a bit deeper during your vendor selection activities to understand what certain companies do best — their “sweet spot.”
It is critically important for many of today’s drug candidates to select the right physical form early in development to ensure the active ingredient can be delivered in the optimum fashion.
Taking a potential drug from candidate selection through clinical development and eventual commercialization is a challenging process. It is not a question of if something unexpected will happen, but when. And when the inevitable problem occurs, how will your CDMO tackle this situation?
This five-part series explores several key questions to consider as part of the CDMO selection process. The first question: Are You Getting The Full Value Of An Integrated Offering?